Niamh M. Troy

Niamh M. Troy

Auto-generated profile, based on publicly available information

Niamh M. Troy

Telethon Kids Institute, The University of Western Australia, Perth, Australia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Cell Host & Microbe
Verified
Journal Article
Closed access
STShu Mei Teo
Shu Mei Teo
DMDanny Mok
Danny Mok
KPKym Pham
Kym Pham
MKMerci Kusel
Merci Kusel
MSMichael Serralha
Michael Serralha
MIMichael Inouye
Michael Inouye

1 September 2018 in Cell Host & Microbe
Verified
Journal Article
Closed access
STShu Mei Teo
Shu Mei Teo
HTHoward H.F. Tang
Howard H.F. Tang
DMDanny Mok
Danny Mok
LJLouise M. Judd
Louise M. Judd
SWStephen C. Watts
Stephen C. Watts
MIMichael Inouye
Michael Inouye

1 September 2011 in Virulence
Verified
Journal Article
Open access
JFJohn P. Fallon
John P. Fallon
NTNiamh Troy
Niamh Troy
KKKevin Kavanagh
Kevin Kavanagh
Larvae of Galleria mellonella are useful models for studying the virulence of microbial pathogens or for evaluating the potency of antimicrobial agents. In this work we demonstrated that prior exposure of larvae to non-lethal doses of Aspergillus fumigatus conidia increases the resistance of larvae to a lethal dose (1 x 107 20 μl-1) 24 h later. Exposure of larvae to a conidia concentration of 1 x 104 20 μl-1 leads to an increase in haemocyte density but an inoculum of 1 x 105 conidia leads to enhanced expression of antimicrobial peptides, increased binding of proteins (e.g. arylophorin, prophenoloxidase, apolipophorin ) to conidia and elevated hemocytes density. These results suggest that a low dose of conidia (1 x 104) predominantly activates the cellular immune response but that a higher dose (1 x 105) that is still not lethal activates a humoral immune response to the greatest extent. While insects have an immune system analogous to the innate immune response of mammals these results suggest that it is...

15 May 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
PVPunnam Chander Veerati
Punnam Chander Veerati
NTNiamh M. Troy
Niamh M. Troy
ARAndrew T. Reid
Andrew T. Reid
NLNgan Fung Li
Ngan Fung Li
KNKristy S. Nichol
Kristy S. Nichol
NBNathan W. Bartlett
Nathan W. Bartlett
Respiratory viral infections, particularly those caused by rhinovirus, exacerbate chronic respiratory inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). Airway epithelial cells are the primary site of rhinovirus replication and responsible of initiating the host immune response to infection. Numerous studies have reported that the anti-viral innate immune response (including type I and type III interferon) in asthma is less effective or deficient leading to the conclusion that epithelial innate immunity is a key determinant of disease severity during a rhinovirus induced exacerbation. However, deficient rhinovirus-induced epithelial interferon production in asthma has not always been observed. We hypothesized that disparate in vitro airway epithelial infection models using high multiplicity of infection (MOI) and lacking genome-wide, time course analyses have obscured the role of epithelial innate anti-viral immunity in asthma and COPD. To address this, we developed a low MOI rhinovirus model of differentiated primary epithelial cells obtained from healthy, asthma and COPD donors. Using genome-wide gene expression following infection, we demonstrated that gene expression patterns are similar across patient groups, but that the kinetics of induction are delayed in cells obtained from asthma and COPD donors. Rhinovirus-induced innate immune responses were defined by interferons (type-I, II, and III), interferon response factors (IRF1, IRF3, and IRF7), TLR signaling and NF-κB and STAT1 activation. Induced gene expression was evident at 24 h and peaked at 48 h post-infection in cells from healthy subjects. In contrast, in cells from donors with asthma or COPD induction was maximal at or beyond 72–96 h post-infection. Thus, we propose that propensity for viral exacerbations of asthma and COPD relate to delayed (rather than deficient) expression of epithelial cell innate anti-viral immune genes which in turns leads to a delayed and ultimately more inflammatory host immune response.

21 November 2016 in Respiratory Research
Verified
Journal Article
Open access
PDF file
NTNiamh M. Troy
Niamh M. Troy
ABAnthony Bosco
Anthony Bosco
Respiratory viral infections are a leading cause of disease and mortality. The severity of these illnesses can vary markedly from mild or asymptomatic upper airway infections to severe wheezing, bronchiolitis or pneumonia. In this article, we review the viral sensing pathways and organizing principles that govern the innate immune response to infection. Then, we reconstruct the molecular networks that differentiate symptomatic from asymptomatic respiratory viral infections, and identify the underlying molecular drivers of these networks. Finally, we discuss unique aspects of the biology and pathogenesis of infections with respiratory syncytial virus, rhinovirus and influenza, drawing on insights from genomics.

15 March 2019 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
SKSiew-Kim Khoo
Siew-Kim Khoo
JRJames Read
James Read
KFKimberley Franks
Kimberley Franks
GZGuicheng Zhang
Guicheng Zhang
JBJoelene Bizzintino
Joelene Bizzintino
ABAnthony Bosco
Anthony Bosco
Asthma exacerbations are triggered by rhinovirus infections. We employed a systems biology approach to delineate upper-airway gene network patterns underlying asthma exacerbation phenotypes in children. Cluster analysis unveiled distinct IRF7hi versus IRF7lo molecular phenotypes, the former exhibiting robust upregulation of Th1/type I IFN responses and the latter an alternative signature marked by upregulation of cytokine and growth factor signaling and downregulation of IFN-γ. The two phenotypes also produced distinct clinical phenotypes. For IRF7lo children, symptom duration prior to hospital presentation was more than twice as long from initial symptoms (p = 0.011) and nearly three times as long for cough (p < 0.001), the odds ratio of admission to hospital was increased more than 4-fold (p = 0.018), and time to recurrence was shorter (p = 0.015). In summary, our findings demonstrate that asthma exacerbations in children can be divided into IRF7hi versus IRF7lo phenotypes with associated differences in clinical phenotypes.